Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Th17 immune responses contribute to the pathophysiology of aplastic anemia.

    ... the severity of BM failure with significantly higher platelet (P < .01) and total BM cell (P < .05) counts at day 10. ...

    Research Article last updated 10/11/2011 - 5:58pm.

  2. Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors.

    ... patients aged over 40 years had a lower likelihood of platelet recovery compared to patients aged less than 20 years (OR 0.45, ...

    Research Article last updated 10/11/2011 - 5:58pm.

  3. Types of Blood Transfusions

    ... Red blood cell transfusion Platelet transfusion More on Transfusions What is a Blood ... blood transfusions than any other part of the blood. Platelet Transfusions Platelets are bits of cells in the blood that help ...

    Page last updated 10/31/2014 - 2:34pm.

  4. A Phase 1 Study of Oral ARRY-614, a p38 MAPK/Tie2 Dual Inhibitor, in Patients with Low or Intermediate 1 Risk Myelodysplastic Syndromes

    ... achieved transfusion independence (TI) and 5 of 7 platelet TD patients achieved TI. Conclusions: ARRY-614 was well tolerated ...

    Research Article last updated 01/20/2015 - 1:07pm.

  5. Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

    ... complete remission, hematologic improvement, or RBC or platelet transfusion independence) was 35% in previously treated patients ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): An initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC)

    ... of IST; the use of specific hemoglobin and platelet levels as triggers for transfusion support; the use of ...

    Research Article last updated 12/17/2013 - 8:30am.

  7. Keith McCrae, MD

    ... have analyzed the levels of circulating endothelial cell, platelet , monocyte , and red blood cell -derived microparticles and ... patients compared to normal controls. The endothelial cell, platelet, and monocyte-derived microparticle levels do not appear significantly ...

    Grant Recipient last updated 02/27/2017 - 7:05am.

  8. A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)

    ... . Eltrombopag has been shown to increase platelet counts in patients with thrombocytopenia from various etiologies ( ... intermediate-2 or high risk MDS by IPSS, and baseline platelet count of <75 Giga (10^9) per liter (Gi/L) will only be enrolled. This ...

    Clinical Trial last updated 04/27/2016 - 1:28pm.

  9. Mary Swift

    ... with a rare blood disorder. I was bruising easily, and my  platelet  count was dangerously low. I was diagnosed to have ITP, had my ...

    Patient Chronicle last updated 03/01/2017 - 11:56am.

  10. Clone of Patients

    ...

    Page last updated 03/14/2016 - 6:05pm.